Drug Database · Clinicians

Hydrochlorothiazide + Imidapril

Brands (2) NORPLUS, VascorideShow all

ACE inhibitors / diuretics; Angiotensin converting enzyme (ACE) inhibitor / diuretic PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH productsVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: INDICATIONS AND USAGE Hydrochlorothiazide is indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. US FDA label

  • Use: Hypertension, including renal parenchymal hypertension renalcarematters.com, reviewed

    Kidney dosing: Imidapril (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Usual: 5 to 10 mg once daily (Singapore NDF).
    CrCl 30–59 mL/min
    Hypertension with kidney impairment: start 2.5 mg once daily and titrate (Singapore NDF). Monitor potassium and creatinine.
    CrCl 15–29 mL/min
    CrCl <30 mL/min (or serum creatinine above 3 mg/dL): use with care; consider halving the usual dose or extending the dosing interval. Start at 2.5 mg once daily in hypertension with kidney impairment (Singapore NDF). Monitor potassium and creatinine.
    CrCl <15 mL/min (not on dialysis)
    CrCl <30 mL/min (or serum creatinine above 3 mg/dL): use with care; consider halving the usual dose or extending the dosing interval. Start at 2.5 mg once daily in hypertension with kidney impairment (Singapore NDF). Monitor potassium and creatinine.
    Hemodialysis (intermittent)
    Hemodialysis with AN69 (polyacrylonitrile) membranes is contraindicated (anaphylactoid reactions). Dose as for CrCl <30 (half dose or longer interval); no dialysis-specific dosing given (Singapore NDF).
    Peritoneal dialysis
    Dose as for CrCl <30; no PD-specific data.
    CRRT
    No data; avoid starting ACE inhibitors in acute kidney injury.
    • Dialyzable? Not stated.
    • Monitoring Potassium and creatinine after starting and dose changes; blood pressure (excess hypotension); angioedema (Singapore NDF). Recheck creatinine and potassium after starting or increasing the dose; continue unless creatinine rises by more than 30% within 4 weeks, and investigate larger rises (renal artery stenosis, volume depletion, NSAIDs). Continue even when eGFR falls below 30 unless not tolerated (KDIGO 2024).

    From the Imidapril monograph (renalcarematters.com, reviewed).

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Tablet: 10 mg/12.5 mg

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Hydrochlorothiazide + Imidapril as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Hydrochlorothiazide + Imidapril
Package insert
NORPLUSImidapril Hydrochloride + Hydrochlorothiazide
10 mg/12.5 mg TabletAluminum Flex Foil x 10's Box of 100's
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DRP-10045
Sep 18, 2027
VascorideImidapril Hydrochloride + Hydrochlorothiazide
10 mg/12.5 mg TabletAluminum Flex Foil x 10's (Box of 50's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DRP-11919
Sep 12, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .